These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2154780)

  • 1. Investigation of the mechanism by which sigma ligands inhibit stimulation of phosphoinositide metabolism by muscarinic cholinergic agonists.
    Bowen WD; Tolentino P; Varghese P
    Prog Clin Biol Res; 1990; 328():21-4. PubMed ID: 2154780
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of the enantiomers of cis-N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1- pyrrolidinyl)cyclohexylamine (BD737 and BD738): novel compounds with high affinity, selectivity and biological efficacy at sigma receptors.
    Bowen WD; Walker JM; de Costa BR; Wu R; Tolentino PJ; Finn D; Rothman RB; Rice KC
    J Pharmacol Exp Ther; 1992 Jul; 262(1):32-40. PubMed ID: 1320690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sigma receptors negatively modulate agonist-stimulated phosphoinositide metabolism in rat brain.
    Bowen WD; Kirschner BN; Newman AH; Rice KC
    Eur J Pharmacol; 1988 May; 149(3):399-400. PubMed ID: 2842167
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of cholinergic muscarinic receptor-stimulated phosphoinositide metabolism in brain from immature rats.
    Balduini W; Murphy SD; Costa LG
    J Pharmacol Exp Ther; 1990 May; 253(2):573-9. PubMed ID: 2160000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Specific binding of N-allylnormetazocine (SKF 10047), a ligand of sigma-opioid receptors, with liver membranes].
    Samovilova NN; Iarygin KN; Vinogradov VA
    Bioorg Khim; 1985 Oct; 11(10):1380-4. PubMed ID: 3000388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of acetylcholine and other agents on 32P-prelabeled phosphoinositides and phosphatidate in crude synaptosomal preparations.
    White HL
    J Neurosci Res; 1988 May; 20(1):122-8. PubMed ID: 2843654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H1 antihistamines interact with central sigma receptors.
    Gray NM; Contreras PC; Allen SE; Taylor DP
    Life Sci; 1990; 47(2):175-80. PubMed ID: 1975080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. M1 muscarinic antagonists interact with sigma recognition sites.
    Hudkins RL; DeHaven-Hudkins DL
    Life Sci; 1991; 49(17):1229-35. PubMed ID: 1658507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of serotoninergic to muscarinic cholinergic stimulation of phosphoinositide-specific phospholipase C in rat brain cortical membranes.
    Wallace MA; Claro E
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1296-300. PubMed ID: 2175801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of sigma receptors by chronic haloperidol.
    Matsumoto RR; Bowen WD; Walker JM
    Prog Clin Biol Res; 1990; 328():125-8. PubMed ID: 2154764
    [No Abstract]   [Full Text] [Related]  

  • 11. Desensitization of muscarinic stimulated hippocampal cell firing is related to phosphoinositide hydrolysis and inhibited by lithium.
    Pontzer NJ; Crews FT
    J Pharmacol Exp Ther; 1990 Jun; 253(3):921-9. PubMed ID: 2162952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental changes in muscarinic receptor-stimulated phosphoinositide metabolism in rat brain.
    Balduini W; Murphy SD; Costa LG
    J Pharmacol Exp Ther; 1987 May; 241(2):421-7. PubMed ID: 3033215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of corticotropin on the rate of 32P-orthophosphate incorporation into the synaptosome phosphoinositides of the ischemic rat brain].
    Pavlinova LI; Tiul'kova EI; Gasteva SV
    Biull Eksp Biol Med; 1987 Jan; 103(1):45-7. PubMed ID: 3026517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cholinergic stimulation on phosphatidylinositol turnover in rat atrium.
    Sekar MC; Roufogalis BD
    Proc West Pharmacol Soc; 1982; 25():69-71. PubMed ID: 6126885
    [No Abstract]   [Full Text] [Related]  

  • 15. Modulation of brain NMDA receptors: common mechanism of sigma/PCP receptors and their exogenous and endogenous ligands.
    Sircar R; Samaan H; Nichtenhauser R; Snell LD; Johnson KM; Rivier J; Vale W; Zukin RS; Zukin SR
    NIDA Res Monogr; 1986; 75():157-60. PubMed ID: 2828962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antimycin A on receptor-activated calcium mobilization and phosphoinositide metabolism in rat parotid gland.
    Poggioli J; Weiss SJ; McKinney JS; Putney JW
    Mol Pharmacol; 1983 Jan; 23(1):71-7. PubMed ID: 6306427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Disorders of polyphosphatidylinosite metabolism in the synaptosomes of the cerebral hemispheres at different periods of ischemia and during recirculation].
    Pavlinova LI; Tiul'kova EI
    Patol Fiziol Eksp Ter; 1987; (6):27-9. PubMed ID: 2832808
    [No Abstract]   [Full Text] [Related]  

  • 18. Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase.
    Gil DW; Wolfe BB
    J Pharmacol Exp Ther; 1985 Mar; 232(3):608-16. PubMed ID: 2579230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The binding and analgesic properties of a sigma opiate, SKF 10,047.
    Pasternak GW; Carroll-Buatti M; Spiegel K
    J Pharmacol Exp Ther; 1981 Oct; 219(1):192-8. PubMed ID: 6270299
    [No Abstract]   [Full Text] [Related]  

  • 20. Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain.
    Raiteri M; Leardi R; Marchi M
    J Pharmacol Exp Ther; 1984 Jan; 228(1):209-14. PubMed ID: 6141277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.